The Prognostic Value of Tertiary Lymphatic Structure in Esophageal Squamous Cell Carcinoma

Tianjin Medical University Cancer Institute and Hospital359 enrolled

Overview

Retrospective analysis of the presence and maturity of tertiary lymphoid structures in pathological sections of patients with esophageal squamous cell carcinoma after surgical treatment. Pay attention to the overall survival and disease free survival of these esophageal squamous cell carcinoma patients.

Study Type

OBSERVATIONAL

Enrollment

359

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

no-InterventionOTHER

no-Intervention

Eligibility

Sex: ALLMin age: 18 YearsMax age: 85 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 1\. Pathologically diagnosed as esophageal squamous cell carcinoma; 2. Surgery for esophageal cancer; 3. Complete medical records; Exclusion Criteria: * Patients with a previous history of malignant tumor

Locations (1)

Tianjin Cancer Hospital

Tianjin, Tianjin Municipality, China

Outcomes

Primary Outcomes

Overall Survival

Time frame: The time from treatment to death or last follow-up, assessed up to 100 months.

DFS

Disease-free Survival

Time frame: The time from treatment to the first recurrence or last follow-up, assessed up to 100 months.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.